440 related articles for article (PubMed ID: 32507912)
1. Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
Gires O; Pan M; Schinke H; Canis M; Baeuerle PA
Cancer Metastasis Rev; 2020 Sep; 39(3):969-987. PubMed ID: 32507912
[TBL] [Abstract][Full Text] [Related]
2. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.
Brown TC; Sankpal NV; Gillanders WE
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209658
[TBL] [Abstract][Full Text] [Related]
3. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.
Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J
BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846
[TBL] [Abstract][Full Text] [Related]
4. A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial-mesenchymal transition in cancer.
Sankpal NV; Fleming TP; Sharma PK; Wiedner HJ; Gillanders WE
Oncogene; 2017 Jun; 36(26):3706-3717. PubMed ID: 28192403
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the Roles of Pro-Metastatic EpCAM in Cancer.
Mohtar MA; Syafruddin SE; Nasir SN; Low TY
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32046162
[TBL] [Abstract][Full Text] [Related]
6. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis.
Liu X; Li J; Cadilha BL; Markota A; Voigt C; Huang Z; Lin PP; Wang DD; Dai J; Kranz G; Krandick A; Libl D; Zitzelsberger H; Zagorski I; Braselmann H; Pan M; Zhu S; Huang Y; Niedermeyer S; Reichel CA; Uhl B; Briukhovetska D; Suárez J; Kobold S; Gires O; Wang H
Sci Adv; 2019 Jun; 5(6):eaav4275. PubMed ID: 31223646
[TBL] [Abstract][Full Text] [Related]
8. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
Wang MH; Sun R; Zhou XM; Zhang MY; Lu JB; Yang Y; Zeng LS; Yang XZ; Shi L; Xiao RW; Wang HY; Mai SJ
Cell Death Dis; 2018 Jan; 9(1):2. PubMed ID: 29305578
[TBL] [Abstract][Full Text] [Related]
9. Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells.
Eslami-S Z; Cortés-Hernández LE; Alix-Panabières C
Cells; 2020 Aug; 9(8):. PubMed ID: 32764280
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer.
Shi R; Liu L; Wang F; He Y; Niu Y; Wang C; Zhang X; Zhang X; Zhang H; Chen M; Wang Y
Cell Signal; 2020 Dec; 76():109810. PubMed ID: 33069797
[TBL] [Abstract][Full Text] [Related]
12. Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences.
Gires O; Stoecklein NH
Cell Mol Life Sci; 2014 Nov; 71(22):4393-402. PubMed ID: 25103341
[TBL] [Abstract][Full Text] [Related]
13. Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells.
Liu X; Yang L; Zhang D; Liu T; Yan Q; Yang X
J Cell Physiol; 2019 Apr; 234(4):4504-4514. PubMed ID: 30246502
[TBL] [Abstract][Full Text] [Related]
14. Epithelial cell adhesion molecule promotes breast cancer resistance protein-mediated multidrug resistance in breast cancer by inducing partial epithelial-mesenchymal transition.
Shi RZ; He YF; Wen J; Niu YN; Gao Y; Liu LH; Zhang XP; Wang Y; Zhang XL; Zhang HF; Chen M; Hu XL
Cell Biol Int; 2021 Aug; 45(8):1644-1653. PubMed ID: 33760350
[TBL] [Abstract][Full Text] [Related]
15. The role of EpCAM in physiology and pathology of the epithelium.
Martowicz A; Seeber A; Untergasser G
Histol Histopathol; 2016 Apr; 31(4):349-55. PubMed ID: 26493939
[TBL] [Abstract][Full Text] [Related]
16. EpCAM duality becomes this molecule in a new Dr. Jekyll and Mr. Hyde tale.
Herreros-Pomares A; Aguilar-Gallardo C; Calabuig-Fariñas S; Sirera R; Jantus-Lewintre E; Camps C
Crit Rev Oncol Hematol; 2018 Jun; 126():52-63. PubMed ID: 29759567
[TBL] [Abstract][Full Text] [Related]
17. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
Patriarca C; Macchi RM; Marschner AK; Mellstedt H
Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
[TBL] [Abstract][Full Text] [Related]
18. A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor.
Tretter JY; Schorpp K; Luxenburger E; Trambauer J; Steiner H; Hadian K; Gires O; Niessing D
J Biol Chem; 2018 Jun; 293(23):8994-9005. PubMed ID: 29700109
[TBL] [Abstract][Full Text] [Related]
19. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
20. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
